Literature DB >> 28244491

Cancer: a new role for non-canonical Hippo signaling.

Jonathan Cooper1, Filippo G Giancotti2.   

Abstract

The molecular mechanisms governing self-renewal and differentiation of the mammary epithelium are incompletely defined; a better understanding of the events implicated in the specification and expansion of luminal progenitors is of particular importance as many breast cancers originate from their transformation. Britschgi et al. found that, in addition to phosphorylating and inactivating YAP, LATS functions as a scaffold to facilitate estrogen receptor-α ubiquitylation by the E3 ligase CRL4 and consequently suppresses luminal progenitor specification and expansion.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28244491      PMCID: PMC5385614          DOI: 10.1038/cr.2017.27

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  12 in total

1.  Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.

Authors:  Wei Li; Jonathan Cooper; Lu Zhou; Chenyi Yang; Hediye Erdjument-Bromage; David Zagzag; Matija Snuderl; Marc Ladanyi; C Oliver Hanemann; Pengbo Zhou; Matthias A Karajannis; Filippo G Giancotti
Journal:  Cancer Cell       Date:  2014-07-14       Impact factor: 31.743

Review 2.  Integrated morphodynamic signalling of the mammary gland.

Authors:  Nikolce Gjorevski; Celeste M Nelson
Journal:  Nat Rev Mol Cell Biol       Date:  2011-08-10       Impact factor: 94.444

Review 3.  Deregulation of cell signaling in cancer.

Authors:  Filippo G Giancotti
Journal:  FEBS Lett       Date:  2014-02-20       Impact factor: 4.124

4.  Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon.

Authors:  Michael Overholtzer; Jianmin Zhang; Gromoslaw A Smolen; Beth Muir; Wenmei Li; Dennis C Sgroi; Chu-Xia Deng; Joan S Brugge; Daniel A Haber
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-07       Impact factor: 11.205

5.  Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus.

Authors:  Wei Li; Liru You; Jonathan Cooper; Gaia Schiavon; Angela Pepe-Caprio; Lu Zhou; Ryohei Ishii; Marco Giovannini; C Oliver Hanemann; Stephen B Long; Hediye Erdjument-Bromage; Pengbo Zhou; Paul Tempst; Filippo G Giancotti
Journal:  Cell       Date:  2010-02-19       Impact factor: 41.582

6.  Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction.

Authors:  M A St John; W Tao; X Fei; R Fukumoto; M L Carcangiu; D G Brownstein; A F Parlow; J McGrath; T Xu
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

7.  Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers.

Authors:  Elgene Lim; François Vaillant; Di Wu; Natasha C Forrest; Bhupinder Pal; Adam H Hart; Marie-Liesse Asselin-Labat; David E Gyorki; Teresa Ward; Audrey Partanen; Frank Feleppa; Lily I Huschtscha; Heather J Thorne; Stephen B Fox; Max Yan; Juliet D French; Melissa A Brown; Gordon K Smyth; Jane E Visvader; Geoffrey J Lindeman
Journal:  Nat Med       Date:  2009-08-02       Impact factor: 53.440

8.  The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα.

Authors:  Adrian Britschgi; Stephan Duss; Sungeun Kim; Joana Pinto Couto; Heike Brinkhaus; Shany Koren; Duvini De Silva; Kirsten D Mertz; Daniela Kaup; Zsuzsanna Varga; Hans Voshol; Alexandra Vissieres; Cedric Leroy; Tim Roloff; Michael B Stadler; Christina H Scheel; Loren J Miraglia; Anthony P Orth; Ghislain M C Bonamy; Venkateshwar A Reddy; Mohamed Bentires-Alj
Journal:  Nature       Date:  2017-01-09       Impact factor: 49.962

9.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.

Authors:  Christina Curtis; Sohrab P Shah; Suet-Feung Chin; Gulisa Turashvili; Oscar M Rueda; Mark J Dunning; Doug Speed; Andy G Lynch; Shamith Samarajiwa; Yinyin Yuan; Stefan Gräf; Gavin Ha; Gholamreza Haffari; Ali Bashashati; Roslin Russell; Steven McKinney; Anita Langerød; Andrew Green; Elena Provenzano; Gordon Wishart; Sarah Pinder; Peter Watson; Florian Markowetz; Leigh Murphy; Ian Ellis; Arnie Purushotham; Anne-Lise Børresen-Dale; James D Brenton; Simon Tavaré; Carlos Caldas; Samuel Aparicio
Journal:  Nature       Date:  2012-04-18       Impact factor: 49.962

Review 10.  Mechanisms of Hippo pathway regulation.

Authors:  Zhipeng Meng; Toshiro Moroishi; Kun-Liang Guan
Journal:  Genes Dev       Date:  2016-01-01       Impact factor: 11.361

View more
  2 in total

Review 1.  The role of Hippo signal pathway in breast cancer metastasis.

Authors:  Changran Wei; Ying Wang; Xiangqi Li
Journal:  Onco Targets Ther       Date:  2018-04-17       Impact factor: 4.147

2.  ARSD, a novel ERα downstream target gene, inhibits proliferation and migration of breast cancer cells via activating Hippo/YAP pathway.

Authors:  Yun Lin; Chun Li; Wei Xiong; Liping Fan; Hongchao Pan; Yaochen Li
Journal:  Cell Death Dis       Date:  2021-11-02       Impact factor: 8.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.